These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9233782

  • 1. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC).
    Zou TT, Lei J, Shi YQ, Yin J, Wang S, Souza RF, Kong D, Shimada Y, Smolinski KN, Greenwald BD, Abraham JM, Harpaz N, Meltzer SJ.
    Oncogene; 1997 Jul 03; 15(1):101-5. PubMed ID: 9233782
    [Abstract] [Full Text] [Related]

  • 2. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.
    Cancer Res; 1997 Sep 01; 57(17):3664-8. PubMed ID: 9288768
    [Abstract] [Full Text] [Related]

  • 4. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
    Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Muñoz N, Bosch FX, Shah K, Cho KR.
    Cancer Res; 1997 Nov 01; 57(21):4692-8. PubMed ID: 9354423
    [Abstract] [Full Text] [Related]

  • 5. Loss of FHIT expression in gastric carcinoma.
    Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K.
    Cancer Res; 1998 Oct 15; 58(20):4708-14. PubMed ID: 9788626
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R.
    Genes Chromosomes Cancer; 1997 Sep 15; 20(1):98-102. PubMed ID: 9290961
    [Abstract] [Full Text] [Related]

  • 7. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID, Szeles A, Yang Y, Klein G, Imreh S.
    Cancer Res; 2000 Dec 15; 60(24):7119-25. PubMed ID: 11156420
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
    Kisielewski AE, Xiao GH, Liu SC, Klein-Szanto AJ, Novara M, Sina J, Bleicher K, Yeung RS, Goodrow TL.
    Oncogene; 1998 Jul 09; 17(1):83-91. PubMed ID: 9671317
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
    Mao L, Fan YH, Lotan R, Hong WK.
    Cancer Res; 1996 Nov 15; 56(22):5128-31. PubMed ID: 8912845
    [Abstract] [Full Text] [Related]

  • 13. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.
    Bugert P, Wilhelm M, Kovacs G.
    Genes Chromosomes Cancer; 1997 Sep 15; 20(1):9-15. PubMed ID: 9290948
    [Abstract] [Full Text] [Related]

  • 14. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT.
    Cancer Res; 1998 May 01; 58(9):1804-7. PubMed ID: 9581816
    [Abstract] [Full Text] [Related]

  • 15. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX, Huang XP, Zhao CX, Xu X, Han YL, Cai Y, Wu RL, Wu M, Zhan QM, Wang MR.
    Ai Zheng; 2004 Sep 01; 23(9):992-8. PubMed ID: 15363189
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.
    Ishii H, Dumon KR, Vecchione A, Trapasso F, Mimori K, Alder H, Mori M, Sozzi G, Baffa R, Huebner K, Croce CM.
    Cancer Res; 2001 Feb 15; 61(4):1578-84. PubMed ID: 11245468
    [Abstract] [Full Text] [Related]

  • 18. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K.
    Cancer Res; 1998 Aug 01; 58(15):3429-34. PubMed ID: 9699676
    [Abstract] [Full Text] [Related]

  • 19. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L, Chieco P, Di Tomaso M, Masi L, Piscaglia F, Brillanti S, Gaiani S, Valgimigli M, Mazziotti A, Bolondi L.
    Clin Cancer Res; 1999 Nov 01; 5(11):3468-75. PubMed ID: 10589760
    [Abstract] [Full Text] [Related]

  • 20. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
    Hendricks DT, Taylor R, Reed M, Birrer MJ.
    Cancer Res; 1997 Jun 01; 57(11):2112-5. PubMed ID: 9187105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.